The Ministry of Health and Prevention (MoHAP) in the UAE has signed a Memorandum of Understanding (MoU) with Sanofi, to promote healthy lifestyles, advance early detection of noncommunicable diseases, and address their associated risk factors.
The agreement is part of MoHAP’s efforts to develop institutional partnerships that strengthen the quality of public health and improve the efficiency of the preventive care system. It will contribute to developing innovative programmes that boost the UAE’s global competitiveness in health indicators, while advancing the objectives of the National Strategy for Wellbeing 2031.
The MoU was signed at the Ministry’s headquarters in Dubai by Dr Hussain Abdul Rahman Al Rand, Assistant Undersecretary for the Public Health Sector at MoHAP, and Preeti Futnani, Country chair and General Manager at Sanofi, in the presence of officials from both sides.
The partnership aims to promote collaboration to prevent chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD) and bronchial asthma, while addressing tobacco consumption, the primary cause of these illnesses. It also aims to improve early identification of related complications and reduce incidence rates.
The MoU supports respiratory disease research conducted in cooperation with national health and academic institutions, including analytical and surveillance studies, clinical trials, and the publication of peer-reviewed scientific literature.
